186 cancer survivors with severe cancer-related fatigue, depression and/or fear of cancer recurrence. More specific, patients after esophageal, hematological malignancy treated with allogeneic stem cell transplantation, and patients after breast cancer are included in this study. Exclusion criteria: psychotic symptoms, manic symptoms, comorbid epilepsy, the use of tricyclic antidepressants.